The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

Hemophilia B

Prevalence: ~30K

hematologic

Official·OMIM:306900 Official·ORPHA101

Inherited bleeding disorder due to factor IX deficiency.

Approved Therapies

Hemgenix (etranacogene dezaparvovec)

FDA Approved11/22/2022AAV Gene Therapy

Associated Genes

F9Coagulation Factor IX

Chromosome XX-Linked Recessive